Want to create an interactive transcript for this episode?
Podcast: Clinician's Roundtable
Episode: Uncovering the Disease Burden of Untreated Pediatric TK2 Deficiency
Description:
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Cristina DomÃnguez González, MD, PhD
How fast does thymidine kinase 2 deficiency (TK2d) progress without intervention? That’s the question explored by the largest dataset to date on untreated pediatric-onset TK2d, and the results reveal a median survival of just 2.6 years from symptom onset. Additionally, more than 80% lost at least one motor milestone, and many experienced escalating care needs, including ventilatory and feeding tube support. Here with Dr. Charles Turck to discuss the findings that highlight the urgent need for earlier diagnosis and intervention is Dr. Cristina Domi...